C4 Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.64 | -$0.02 | -$0.36 |
| Q2 2024 | 2 | -$0.64 | -$0.02 | -$0.36 |
| Q3 2024 | 2 | -$0.67 | -$0.02 | -$0.38 |
| Q4 2024 | 6 | -$0.69 | -$0.29 | -$0.46 |
| Q1 2025 | 2 | $0.01 | $0.33 | $0.19 |
| Q2 2025 | 1 | -$0.76 | -$0.02 | -$0.43 |
| Q3 2025 | 1 | -$0.71 | -$0.02 | -$0.40 |
| Q4 2025 | 1 | -$0.76 | -$0.02 | -$0.43 |
C4 Therapeutics, Inc. Earnings Date And Information
C4 Therapeutics, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $-0.35 earnings per share for the quarter, topping analysts' consensus estimates of $-0.4 by $0.05. The company had revenue of 15.36 M for the quarter and had revenue of 20.76 M for the year. C4 Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.67 diluted earnings per share) and currently has a price-to-earnings ratio of -4.02. C4 Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
C4 Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2024 | Q2 2024 | -$0.40 | -$0.35 | 0.05 | $5.90 M | $15.36 M |
| 08/01/2024 | Q1 2024 | -$0.37 | -$0.26 | 0.11 | $4.78 M | $12.01 M |
| 05/08/2024 | Q4 2023 | -$0.41 | -$0.41 | 0 | $3.04 M | |
| 02/22/2024 | Q3 2023 | -$0.67 | -$0.68 | -0.01 | $3.26 M | |
| 11/01/2023 | Q2 2023 | -$0.65 | -$0.55 | 0.1 | $5.28 M | $11.07 M |
| 08/08/2023 | Q1 2023 | -$0.74 | -$0.73 | 0.01 | $6.41 M | $2.66 M |
| 05/04/2023 | Q4 2022 | -$0.78 | -$0.69 | 0.09 | $3.76 M | |
| 02/23/2023 | Q3 2022 | -$0.72 | -$0.74 | -0.02 | $2.85 M | |
| 11/03/2022 | Q2 2022 | -$0.65 | -$0.64 | 0.01 | $8.45 M | $6.75 M |
| 08/04/2022 | Q1 2022 | -$0.68 | -$0.56 | 0.12 | $7.64 M | $13.83 M |
| 05/05/2022 | Q4 2021 | -$0.61 | -$0.66 | -0.05 | $7.65 M | |
| 02/24/2022 | Q3 2021 | -$0.59 | -$0.32 | 0.27 | $20.08 M | |
| 11/10/2021 | Q2 2021 | -$0.60 | -$0.51 | 0.09 | $7.61 M | $8.50 M |
| 08/11/2021 | Q1 2021 | -$0.60 | -$0.51 | 0.09 | $6.29 M | $9.78 M |
| 05/13/2021 | Q4 2020 | -$0.63 | -$0.49 | 0.14 | $7.43 M | |
| 03/11/2021 | Q3 2020 | -$0.53 | -$0.53 | 0 | $8.26 M | |
| 11/12/2020 | Q2 2020 | -$0.79 | -$0.54 | 0.25 | $6.07 M | $8.45 M |
| 06/29/2020 | Q1 2020 | -$0.26 | $9.67 M | |||
| 03/30/2020 | Q4 2019 | -$0.69 | $6.82 M | |||
| 12/30/2019 | Q3 2019 | -$0.58 | $8.21 M |
C4 Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is C4 Therapeutics, Inc.'s earnings date?
C4 Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
Did C4 Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, C4 Therapeutics, Inc. (:CCCC) reported $-0.35 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.4 by $0.05.
-
How can I listen to C4 Therapeutics, Inc.'s earnings conference call?
The conference call for C4 Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read C4 Therapeutics, Inc.'s conference call transcript?
The conference call transcript for C4 Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does C4 Therapeutics, Inc. generate each year?
C4 Therapeutics, Inc. (:CCCC) has a recorded annual revenue of $20.76 M.
-
How much profit does C4 Therapeutics, Inc. generate each year?
C4 Therapeutics, Inc. (:CCCC) has a recorded net income of $20.76 M. C4 Therapeutics, Inc. has generated $-2.67 earnings per share over the last four quarters.
-
What is C4 Therapeutics, Inc.'s price-to-earnings ratio?
C4 Therapeutics, Inc. (:CCCC) has a price-to-earnings ratio of -4.02 and price/earnings-to-growth ratio is -0.14.
